Neurodevelopmental disorder‐causing GRIN1 Y647S variant alters red blood cell physiology in mice
Physiological Reports · 2026
DOI: 10.14814/phy2.70759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2026. Verfasst von Sylvia C Okafor und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Erythrocytes, Nerve Tissue Proteins. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Simons Foundation Autism Research Initiative (SFARI), CureGRIN Research Foundation, Canadian Institutes of Health Research (CIHR).
Abstract (Originalsprache)
GRIN Disorder is a rare neurodevelopmental disease caused by pathogenic variants in GRIN genes encoding subunits of the N‐methyl‐D‐aspartate receptor (NMDAR). GRIN Disorder presents with a wide spectrum of neurological symptoms and currently lacks effective therapeutics and clinically accessible biomarkers to stratify disease severity or monitor treatment response. While NMDARs are well‐studied in the central nervous system, they are also expressed in peripheral blood cells, including red blood cells (RBCs), where they modulate calcium signaling and cell function. Here we have used well‐established in vivo and ex vivo methods to investigate hematological (primarily RBC‐linked) phenotypes in transgenic mice carrying heterozygous Grin1 Y647S (Grin1 Y647S/+ ) variant. We found that Grin1 Y647S/+ mice had slightly increased RBC counts associated with increased erythropoiesis and normal erythropoietin levels. Functional assays revealed increased NMDAR‐mediated calcium influx in Grin1 Y647S/+ RBCs, accompanied by reduced blood viscosity under flow conditions. Our findings provide the first genetic evidence that NMDAR gain‐of‐function leads to systemic changes in RBC physiology, which may contribute to core phenotypes of NMDAR‐related disorders. Results point to several RBC indices that reflect altered NMDAR function in Grin1 Y647S/+ mice, providing foundational evidence for the development of peripheral blood biomarkers for patients with GRIN Disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
- Department of Biology, McMaster University, Hamilton, Ontario, Canada.
- Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario, Canada.
- Canadian Blood Services, Toronto, Ontario, Canada.
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Sylvia C Okafor, Maggie L Kalev-Zylinska, Amy J Ramsey
Förderung
- Simons Foundation Autism Research Initiative (SFARI)
- CureGRIN Research Foundation
- Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Okafor, S. C., Horsfall, W., Finnie, P. S. B., Holicka, C., Wen, T., Khatir, B., Loriamini, M., Salahpour, A., Golovin, K., Branch, D. R., Scott, G. R., Edgar, L. J., Kalev-Zylinska, M. L., & Ramsey, A. J. (2026). Neurodevelopmental disorder‐causing GRIN1 Y647S variant alters red blood cell physiology in mice. Physiological Reports. https://doi.org/10.14814/phy2.70759
Vancouver
Okafor SC, Horsfall W, Finnie PSB, Holicka C, Wen T, Khatir B, et al. Neurodevelopmental disorder‐causing GRIN1 Y647S variant alters red blood cell physiology in mice. Physiological Reports. 2026. doi:10.14814/phy2.70759
BibTeX
@article{Okafor2026,
author = {Okafor, Sylvia C and Horsfall, Wendy and Finnie, Peter S B and Holicka, Caroline and Wen, Tao and Khatir, Behrooz and Loriamini, Melika and Salahpour, Ali and Golovin, Kevin and Branch, Donald R and Scott, Graham R and Edgar, Landon J and Kalev-Zylinska, Maggie L and Ramsey, Amy J},
title = {Neurodevelopmental disorder‐causing GRIN1 Y647S variant alters red blood cell physiology in mice},
journal = {Physiological Reports},
year = {2026},
doi = {10.14814/phy2.70759}
}
EUVIMED